These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28837822)

  • 21. Core-shell structured Fe3O4@TiO2-doxorubicin nanoparticles for targeted chemo-sonodynamic therapy of cancer.
    Shen S; Wu L; Liu J; Xie M; Shen H; Qi X; Yan Y; Ge Y; Jin Y
    Int J Pharm; 2015; 486(1-2):380-8. PubMed ID: 25841570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated self-assembling drug delivery system possessing dual responsive and active targeting for orthotopic ovarian cancer theranostics.
    Lin CJ; Kuan CH; Wang LW; Wu HC; Chen Y; Chang CW; Huang RY; Wang TW
    Biomaterials; 2016 Jun; 90():12-26. PubMed ID: 26974704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo.
    Lu HL; Syu WJ; Nishiyama N; Kataoka K; Lai PS
    J Control Release; 2011 Nov; 155(3):458-64. PubMed ID: 21689700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance.
    He Q; Gao Y; Zhang L; Zhang Z; Gao F; Ji X; Li Y; Shi J
    Biomaterials; 2011 Oct; 32(30):7711-20. PubMed ID: 21816467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An AS1411 aptamer-conjugated liposomal system containing a bubble-generating agent for tumor-specific chemotherapy that overcomes multidrug resistance.
    Liao ZX; Chuang EY; Lin CC; Ho YC; Lin KJ; Cheng PY; Chen KJ; Wei HJ; Sung HW
    J Control Release; 2015 Jun; 208():42-51. PubMed ID: 25637705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioreducible core-crosslinked hyaluronic acid micelle for targeted cancer therapy.
    Han HS; Choi KY; Ko H; Jeon J; Saravanakumar G; Suh YD; Lee DS; Park JH
    J Control Release; 2015 Feb; 200():158-66. PubMed ID: 25550153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging.
    Chen Y; Ai K; Liu J; Sun G; Yin Q; Lu L
    Biomaterials; 2015 Aug; 60():111-20. PubMed ID: 25988726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
    Baghbani F; Moztarzadeh F
    Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment.
    Luo W; Wen G; Yang L; Tang J; Wang J; Wang J; Zhang S; Zhang L; Ma F; Xiao L; Wang Y; Li Y
    Theranostics; 2017; 7(2):452-465. PubMed ID: 28255342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines.
    Zhang Y; Chen W; Yang C; Fan Q; Wu W; Jiang X
    J Control Release; 2016 Sep; 237():115-24. PubMed ID: 27397491
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy.
    Chen D; Li B; Cai S; Wang P; Peng S; Sheng Y; He Y; Gu Y; Chen H
    Biomaterials; 2016 Sep; 100():1-16. PubMed ID: 27236844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Directed Graphene-Based Nanoplatforms for Hyperthermia: Overcoming Multiple Drug Resistance.
    Tu Z; Qiao H; Yan Y; Guday G; Chen W; Adeli M; Haag R
    Angew Chem Int Ed Engl; 2018 Aug; 57(35):11198-11202. PubMed ID: 29905979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A folate modified pH sensitive targeted polymeric micelle alleviated systemic toxicity of doxorubicin (DOX) in multi-drug resistant tumor bearing mice.
    Li X; Yang X; Lin Z; Wang D; Mei D; He B; Wang X; Wang X; Zhang Q; Gao W
    Eur J Pharm Sci; 2015 Aug; 76():95-101. PubMed ID: 25917524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin-induced co-assembling nanomedicines with temperature-sensitive acidic polymer and their in-situ-forming hydrogels for intratumoral administration.
    Wan J; Geng S; Zhao H; Peng X; Zhou Q; Li H; He M; Zhao Y; Yang X; Xu H
    J Control Release; 2016 Aug; 235():328-336. PubMed ID: 27282415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effective delivery of chemotherapeutic nanoparticles by depleting host Kupffer cells.
    Ohara Y; Oda T; Yamada K; Hashimoto S; Akashi Y; Miyamoto R; Kobayashi A; Fukunaga K; Sasaki R; Ohkohchi N
    Int J Cancer; 2012 Nov; 131(10):2402-10. PubMed ID: 22362271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acidity-Triggered Ligand-Presenting Nanoparticles To Overcome Sequential Drug Delivery Barriers to Tumors.
    Wang T; Wang D; Liu J; Feng B; Zhou F; Zhang H; Zhou L; Yin Q; Zhang Z; Cao Z; Yu H; Li Y
    Nano Lett; 2017 Sep; 17(9):5429-5436. PubMed ID: 28753017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal Design of Novel Functionalized Nanoconjugates Based on Polymalic Acid for Efficient Tumor Endocytosis with Enhanced Anticancer Activity.
    Guo S; Zhou Q; Yang T; Qiao Y; Fan L; Wang C; Wu H
    J Biomed Nanotechnol; 2018 Jun; 14(6):1039-1051. PubMed ID: 29843869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.
    Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y
    Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.